[1]
B. Salustio Pires, J. Bratke, J. do Nascimento Santos Costa, M. de Souza Nars, and M. F. Mussolino, “Access to the population, financing and availability times of antineoplastic drugs incorporated into the SUS between 2012 and 2024”, J Assist Farm Farmacoecon, vol. 10, no. 2, Nov. 2025.